Influenza co-infection associated with severity and mortality in COVID-19 patients
Abstract Background In COVID-19 patients, undetected co-infections may have severe clinical implications associated with increased hospitalization, varied treatment approaches and mortality. Therefore, we investigated the implications of viral and bacterial co-infection in COVID-19 clinical outcomes...
Main Authors: | Bandar Alosaimi, Asif Naeem, Maaweya E. Hamed, Haitham S. Alkadi, Thamer Alanazi, Sanaa Saad Al Rehily, Abdullah Z. Almutairi, Adnan Zafar |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-06-01
|
Series: | Virology Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12985-021-01594-0 |
Similar Items
-
Bacterial Outer Membrane Vesicles (OMVs)-Based Dual Vaccine for Influenza A H1N1 Virus and MERS-CoV
by: Mahmoud M. Shehata, et al.
Published: (2019-05-01) -
Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality
by: Bandar Alosaimi, et al.
Published: (2021-07-01) -
History of influenza immunization in COVID-19 patients: impact on mortality
by: Carlos Sánchez-García, et al.
Published: (2021-01-01) -
Co-infection with SARS-CoV-2 and influenza A virus
by: Shuhei Azekawa, et al.
Published: (2020-01-01) -
Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses
by: Zeinab Abdelrahman, et al.
Published: (2020-09-01)